ADPT Sale Disclosure
Robins Chad M · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$64.56K
Robins Chad M CEO And Chairman
Transaction date
Aug 17, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 3 days later
ADPT daily price context
Close on/before transaction
$24.77
Aug 17, 2026
Close before public filing
$25.49
Aug 19, 2026
Return since public filing
+6.59%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,525 shares @ $25.57
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780649-26-000014
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$18.81M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Exercise | Aug 18, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Aug 18, 2026 | $6.82M |
| Adaptive Biotechnologies Corp ADPT | Sale | Aug 18, 2026 | $5.13K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Aug 18, 2026 | $1.83M |
| Adaptive Biotechnologies Corp ADPT | Sale | Aug 17, 2026 | $8M |
| Adaptive Biotechnologies Corp ADPT | Exercise | Aug 17, 2026 | $2.1M |
| Adaptive Biotechnologies Corp ADPT Current | Sale | Aug 17, 2026 | $64.56K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Aug 17, 2026 | $0 |